2BB score and signals
Cullinan Therapeutics, Inc.’s current 2BB score is 12 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 3 | Very Low |
| Momentum | 40 | Weakening |
| Financial strength | 25 | Weak |
| Quality | 100 | Very Strong |
| Risk | 14 | Very Low |
Company facts
| Founded | 2016 |
| Employees | 109 |
| 52-week range | $6.75 – $23.19 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-08 | — | -0.8738 | — | $14.03M |
| 2026-11-05 | — | -0.8661 | — | $0.00 |
| 2026-08-06 | — | -0.826 | — | $0.00 |
| 2026-05-07 | -0.75 | -0.8453 | $0.00 | $0.00 |
Related companies
2BBBullish & Bearish